nic002
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00736047)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- nicotineImmunity, active
nicotine immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nic002
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01280968 | Phase 2 | Dec 1, 2010 | Duke University, Novartis, Wake Forest University |
| NCT00736047 | Phase 2 | Aug 1, 2008 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 2 | 1 | 1 | 2008 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Wake Forest University | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1